U.S

Insights from U.S. Litigation History: Navigating Legal Challenges for GLP-1 Weight-Loss Drug Manufacturers

by

New York – As the battle against obesity intensifies in the United States, the spotlight has turned towards a promising class of weight-loss drugs known as glucagon-like peptide-1 receptor (GLP-1) agonists. These medications, initially developed to treat diabetes, have shown significant efficacy in weight management, offering a new hope for millions struggling with obesity. However, the burgeoning demand and dramatic effects of these drugs have also raised concerns about potential legal challenges that may echo America’s complex history with mass tort litigation involving pharmaceutical companies. The risk of facing massive lawsuits is not misplaced. In … Read more

Justice Department Warns of Potential Chinese Influence Through TikTok on U.S. Elections, Citing National Security Risks

by

WASHINGTON — The Justice Department has expressed concerns that TikTok, owned by the Chinese company ByteDance, could be manipulated to interfere with U.S. politics, according to a recent court filing. This alarm raises the stakes in an ongoing legal battle over whether the popular video-sharing app could continue operating under its Chinese parent company or face a ban due to national security risks. Prosecutors argue that the app’s algorithms could potentially be used by the Chinese government to covertly sway public opinion in the United States, influencing political outcomes and discussions under the guise of … Read more

Weight-Loss Drug Makers Glean Strategic Insights from U.S. Litigation History

by

New York — As the United States grapples with rising obesity rates, manufacturers of the weight-loss drug class known as glucagon-like peptide-1 receptor agonists, or GLP-1, are drawing increased legal scrutiny. With this pharmaceutical success comes a lurking fear of mass tort litigation, a recurring theme in America’s complicated relationship with promising yet potentially risky medications. GLP-1 weight-loss drugs, lauded for their effectiveness in combating obesity, now face the challenge of navigating the perilous waters of American litigation. This scenario isn’t new. The history of pharmaceuticals in the U.S. is replete with legal battles over … Read more

U.S. Lawmakers Introduce Bipartisan Bill to Curb Corporate Bankruptcy Loopholes Amid Johnson & Johnson Controversy

by

Washington, D.C. — A new bipartisan bill is gaining traction in Congress, aimed at addressing a controversial bankruptcy strategy that has been employed by major corporations like Johnson & Johnson. This legal maneuver, known as the “Texas Two-Step,” allows companies to create separate entities to absorb liabilities, particularly those stemming from mass tort litigation, essentially shielding the main corporation from significant financial consequences. The legislative push seeks to overhaul aspects of the U.S. bankruptcy code that currently permit such divisions, a tactic that critics argue undermines the rights of litigants by limiting their ability to … Read more